BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 24844137)

  • 1. Clinical investigational studies for validation of a next-generation sequencing in vitro diagnostic device for cystic fibrosis testing.
    Grosu DS; Hague L; Chelliserry M; Kruglyak KM; Lenta R; Klotzle B; San J; Goldstein WM; Moturi S; Devers P; Woolworth J; Peters E; Elashoff B; Stoerker J; Wolff DJ; Friedman KJ; Highsmith WE; Lin E; Ong FS
    Expert Rev Mol Diagn; 2014 Jun; 14(5):605-22. PubMed ID: 24844137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation for clinical use of, and initial clinical experience with, a novel approach to population-based carrier screening using high-throughput, next-generation DNA sequencing.
    Hallam S; Nelson H; Greger V; Perreault-Micale C; Davie J; Faulkner N; Neitzel D; Casey K; Umbarger MA; Chennagiri N; Kramer AC; Porreca GJ; Kennedy CJ
    J Mol Diagn; 2014 Mar; 16(2):180-9. PubMed ID: 24374108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Confirming Variants in Next-Generation Sequencing Panel Testing by Sanger Sequencing.
    Baudhuin LM; Lagerstedt SA; Klee EW; Fadra N; Oglesbee D; Ferber MJ
    J Mol Diagn; 2015 Jul; 17(4):456-61. PubMed ID: 25960255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Next-generation sequencing: a change of paradigm in molecular diagnostic validation.
    Salto-Tellez M; Gonzalez de Castro D
    J Pathol; 2014 Sep; 234(1):5-10. PubMed ID: 24756835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical diagnostic Next-Generation sequencing: the case of CFTR carrier screening.
    Loukas YL; Thodi G; Molou E; Georgiou V; Dotsikas Y; Schulpis KH
    Scand J Clin Lab Invest; 2015 Sep; 75(5):374-81. PubMed ID: 25874479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification of overlapping DNA amplicons in a single-tube multiplex PCR for targeted next-generation sequencing of BRCA1 and BRCA2.
    Schenk D; Song G; Ke Y; Wang Z
    PLoS One; 2017; 12(7):e0181062. PubMed ID: 28704513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation sequencing for human papillomavirus genotyping.
    Arroyo LS; Smelov V; Bzhalava D; Eklund C; Hultin E; Dillner J
    J Clin Virol; 2013 Oct; 58(2):437-42. PubMed ID: 23932809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays.
    Bijwaard K; Dickey JS; Kelm K; Težak Ž
    Expert Rev Mol Diagn; 2015 Jan; 15(1):33-40. PubMed ID: 25370936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa.
    Wang J; Zhang VW; Feng Y; Tian X; Li FY; Truong C; Wang G; Chiang PW; Lewis RA; Wong LJ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6213-23. PubMed ID: 25097241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing and its applications in molecular diagnostics.
    Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
    Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in clinical next-generation sequencing: target enrichment and sequencing technologies.
    Ballester LY; Luthra R; Kanagal-Shamanna R; Singh RR
    Expert Rev Mol Diagn; 2016; 16(3):357-72. PubMed ID: 26680590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic Evaluation of Sanger Validation of Next-Generation Sequencing Variants.
    Beck TF; Mullikin JC; ; Biesecker LG
    Clin Chem; 2016 Apr; 62(4):647-54. PubMed ID: 26847218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analytical parameters and validation of homopolymer detection in a pyrosequencing-based next generation sequencing system.
    Ivády G; Madar L; Dzsudzsák E; Koczok K; Kappelmayer J; Krulisova V; Macek M; Horváth A; Balogh I
    BMC Genomics; 2018 Feb; 19(1):158. PubMed ID: 29466940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sanger Confirmation Is Required to Achieve Optimal Sensitivity and Specificity in Next-Generation Sequencing Panel Testing.
    Mu W; Lu HM; Chen J; Li S; Elliott AM
    J Mol Diagn; 2016 Nov; 18(6):923-932. PubMed ID: 27720647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
    Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
    Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verification of performance specifications of a molecular test: cystic fibrosis carrier testing using the Luminex liquid bead array.
    Lacbawan FL; Weck KE; Kant JA; Feldman GL; Schrijver I;
    Arch Pathol Lab Med; 2012 Jan; 136(1):14-9. PubMed ID: 22208482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing can replace Sanger sequencing in clinical diagnostics.
    Sikkema-Raddatz B; Johansson LF; de Boer EN; Almomani R; Boven LG; van den Berg MP; van Spaendonck-Zwarts KY; van Tintelen JP; Sijmons RH; Jongbloed JD; Sinke RJ
    Hum Mutat; 2013 Jul; 34(7):1035-42. PubMed ID: 23568810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter validation study for the certification of a CFTR gene scanning method using next generation sequencing technology.
    Bergougnoux A; D'Argenio V; Sollfrank S; Verneau F; Telese A; Postiglione I; Lackner KJ; Claustres M; Castaldo G; Rossman H; Salvatore F; Raynal C
    Clin Chem Lab Med; 2018 Jun; 56(7):1046-1053. PubMed ID: 29427548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Characteristics and Validation of Next-Generation Sequencing for Human Leucocyte Antigen Typing.
    Weimer ET; Montgomery M; Petraroia R; Crawford J; Schmitz JL
    J Mol Diagn; 2016 Sep; 18(5):668-675. PubMed ID: 27376474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Good laboratory practice for clinical next-generation sequencing informatics pipelines.
    Gargis AS; Kalman L; Bick DP; da Silva C; Dimmock DP; Funke BH; Gowrisankar S; Hegde MR; Kulkarni S; Mason CE; Nagarajan R; Voelkerding KV; Worthey EA; Aziz N; Barnes J; Bennett SF; Bisht H; Church DM; Dimitrova Z; Gargis SR; Hafez N; Hambuch T; Hyland FC; Luna RA; MacCannell D; Mann T; McCluskey MR; McDaniel TK; Ganova-Raeva LM; Rehm HL; Reid J; Campo DS; Resnick RB; Ridge PG; Salit ML; Skums P; Wong LJ; Zehnbauer BA; Zook JM; Lubin IM
    Nat Biotechnol; 2015 Jul; 33(7):689-93. PubMed ID: 26154004
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.